Atlas Trials

Residual Plasma Concentration of Sorafenib and Adverse Events in CHC

Clinical trial NCT03340636 · UNKNOWN

Trial details

NCT number
NCT03340636
Sponsor
University Hospital, Caen
Status
UNKNOWN
Study type
OBSERVATIONAL
Advanced or Metastatic Hepatocellular Carcinoma
Start date
2018-01-01
Primary completion
2019-01-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.